Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Academic Performance in Asian Children Aged 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine Hydrochloride

NCT00471354 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00471354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00471354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Academic Performance in Asian Children Aged 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine Hydrochloride
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2007
Completion date
November 30, 2008
Enrollment
228 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder